Vanguard Group Inc Atri Cure, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 4,621,933 shares of ATRC stock, worth $130 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,621,933
Previous 4,752,985
2.76%
Holding current value
$130 Million
Previous $145 Million
27.21%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ATRC
# of Institutions
210Shares Held
49.3MCall Options Held
111KPut Options Held
23.8K-
Black Rock Inc. New York, NY4.62MShares$130 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$118 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$75.4 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$56.3 Million0.05% of portfolio
-
First Light Asset Management, LLC Edina, MN1.96MShares$55.4 Million4.07% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.31B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...